MedicalDevice Licensing.com
Innovaro Pharmalicensing
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Innovaro Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Innovaro Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd
Innovaro Corporation
Industry news

Related news

Latest News

Exploratory trial shows no incremental benefit of aliskiren add-on therapy in improving changes to cardiac shape in heart attack patients
Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the CYPHER
ASP Offers Safety and Convenience to Those Transitioning from 'Just-in-Time' Sterilization to Terminal Sterilization with the Introduction of the ASP OR Solution
NUVO RESEARCH ENROLLS FIRST PATIENT IN PHASE 2 WF10 ALLERGIC RHINITIS TRIAL
Icagen Reports Positive Results for ICA-105665 in Patients With Photosensitive Epilepsy
NEOPROBE TO HOLD LYMPHOSEEK UPDATE CALL
NEOPROBE ANNOUNCES SUCCESSFUL MEETING ON LYMPHOSEEK PHASE 3 RESULTS
NOVELOS THERAPEUTICS BELIEVES CLASS ACTION LAWSUIT IS WITHOUT MERIT AND INTENDS TO DEFEND VIGOROUSLY
ETEX Corporation Announces FDA Clearance and Launch of Carrigen(R) Porous Bone Substitute Material
Harvard Bioscience, Inc. Launches Its First Regenerative Medicine Product
More news... | RSS Feed...

Most Viewed

NEJM Publishes Trial Results Demonstrating Bard FLAIR(R) Endovascular Stent Graft is Superior to Balloon Angioplasty for Failing Dialysis Grafts

Data from a post hoc analysis using desmoteplase in ischaemic stroke presented at the International Stroke Conference

Light Sciences Oncology Meets a Major Milestone in Aptocine Development with Target Enrollment in Phase 3 MCRC Trial

Galapagos successfully completes Phase I clinical trials for rheumatoid arthritis candidate drug GLPG0259

Gilead's Single-Tablet "Quad" Regimen for HIV Achieves a High Rate of Virologic Suppression in Phase II Study

NOVELOS THERAPEUTICS PIVOTAL PHASE 3 LUNG CANCER TRIAL DOES NOT MEET THE PRIMARY SURVIVAL ENDPOINT

Merck Reports Initial Results of Phase III Studies with Vicriviroc in Treatment-Experienced HIV-Infected Patients

Chelsea Therapeutics Supports Initiation of Phase II Study of Droxidopa in Combination With Carbidopa in Adult Attention Deficit Hyperactivity Disorder

New Study Compares Efficacy and Safety of Once-Daily versus Twice-Daily PREZISTA

AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis (RA)

Therapeutic Target

Cardiovascular
Dermatology
Endocrine and Metabolic
Gastroenterology
Genitourinary
Hematology
Immunology and Allergy
Infection
Musculoskeletal
Neurology
Obstetrics and Gynecology
Oncology
Ophthalmology
Psychiatry
Pulmonary

Categories

Deals and Alliances
Development
Financial Results
Financings
Intellectual Property
Regulatory
Press releases
Deals review
Headlines
PR Newswire

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Press releases: Innovaro Pharmalicensing current industry press releases.

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us